MedTrace Logo

Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device

NCT04379986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-10-20

No results posted yet for this study

Summary

During the last couple of years, a growing number of wearable devices evolved to provide accurate, cheap and non-invasive monitoring of vitals parameters.This connected care technology could be helpful for treatment and care during a pandemic such as COVID-19. The use of these non-invasive remote monitoring devices can help health care providers to assess patient's vital signs and symptom progression, reducing reducing patient and healthcare provider contact and exposure to COVID-19 during this pandemic.

Conditions

  • Blood Pressure

Interventions

DEVICE

Senbiosys

The patients will undergo blood pressure estimation as per clinical routine and will simultaneously wear the device.

Sponsors & Collaborators

  • Stéphane Cook, Prof

    lead OTHER

Principal Investigators

  • Stéphane Cook, MD · University of Freiburg

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04379986 on ClinicalTrials.gov